Empowering APOE4 carriers to optimize brain health while advancing Alzheimer's research

The Phoenix Community serves 1.1 billion people worldwide who carry APOE4—the strongest genetic risk factor for Alzheimer's disease.

For our members:
We provide AI-powered biomarker tracking with APOE4-optimized ranges, personalized intervention recommendations based on genetic matches, and a supportive community of peers facing the same genetic odds. No more guessing which supplements work. No more optimizing alone.

For research:
Our members contribute longitudinal health data that accelerates drug development. We connect pharmaceutical and medtech companies with pre-qualified APOE4 cohorts for clinical trials, providing years of baseline data and real-world evidence that transforms how therapies are developed and tested.

The result: Members get cutting-edge insights and early access to breakthrough therapies. Researchers get the data and participants they need. Science moves faster.

Founded by Dr. Kevin Tran (PharmD, APOE4/4 carrier) after his own diagnosis revealed a critical gap in personalized prevention.


The Phoenix Community

Org chart

Teams

Offices

The Phoenix Community

Org chart

Teams

Offices

Related companies